English
Home > Products > CAS NO:1138245-21-2

China CAS NO:1138245-21-2 Factory

We've been also focusing on improving upon the stuff management and QC program to make sure that we could hold fantastic gain in the fiercely-competitive enterprise for CAS NO:1138245-21-2,Mirogabalin besylate API,Mirogabalin API,Mirogabalin besylate,Mirogabalin, Honesty is our principle, professional operation is our work, service is our goal, and customers' satisfaction is our future!
CAS NO:1138245-21-2, Further, we've been supported by highly experienced and knowledgeable professionals, who have immense expertise in their respective domain. These professionals work in close coordination with each other to provide our clients an effective range of goods.

Related Products

Hot Products

  • Potassium hydroxide

    Potassium hydroxide

    Product Name:Potassium hydroxide
    Molecular Formula:KOH
    Molecular Weight:56.11
    CAS Registry Number:1310-58-3
  • Camostat mesilate

    Camostat mesilate

    Product Name:Camostat mesilate
    Molecular Formula:C21H26N4O8S
    Molecular Weight;494.52
    CAS Registry Number;59721-29-8
  • Raltegravir potassium

    Raltegravir potassium

    Product Name:Raltegravir potassium
    Molecular Formula:C20H20FN6O5.K
    Molecular Weight;482.511
    CAS Registry Number;871038-72-1
  • Parecoxib

    Parecoxib

    Product Name:Parecoxib
    Molecular Formula:C19H18N2O4S
    Molecular Weight:370.42
    CAS Registry Number:198470-84-7
  • BOC-HYP-OH

    BOC-HYP-OH

    Product Name:BOC-HYP-OH
    Molecular Formula:C10H17NO5
    Molecular Weight:231.25
    CAS Registry Number:331442-12-7
  • 2-Chloro-3-pyridinamine

    2-Chloro-3-pyridinamine

    Product Name:2-Chloro-3-pyridinamine
    Molecular Formula:C5H5ClN2
    Molecular Weight:128.56
    CAS Registry Number:6298-19-7
  • Related Blog
  • Reviews

  • How is a drug produced?

    ​There are so many different drugs ,with different color /shape ( like capsule ,tablet or Infusion) and price . Here we would like to explain , what makes it so different? How is a drug produced?

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Caffeine CAS No.58-08-2

    Caffeine (CAS No.58-08-2) is a xanthine alkaloid compound, a central nervous stimulant that temporarily drives away drowsiness and restores energy, and is used clinically to treat neurosis and coma recovery. Caffeinated coffee, tea, soft drinks and energy drinks are very popular, so caffeine is also the most commonly used psychotropic drug in the world.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept